News

IBH expands pain and opioid treatment program in workers compensation plans

Integrated Behavioral Health (IBH) is excited to announce the expansion of and enhancements to its pain and opioid treatment program for injured workers covered in a workers compensation plan.  Providing management and programs for early intervention and chronic opioid use treatment, IBH utilized its 30-year history of successfully treating opioid patients to build a specialized,… Read more »

Integrated Behavioral Health, Inc. Announces the Acquisition of Inflexxion, Inc.

COSTA MESA, Calif., July 10, 2018 (Newswire.com) – Integrated Behavioral Health, Inc. (“IBH”), today announced the acquisition of Inflexxion, Inc. (“Inflexxion” or the “Company”), a healthcare data and analytics company that specializes in the collection, surveillance, monitoring and analysis of critical public health issues including prescription drug abuse, substance use, behavioral health, and pain management…. Read more »

PainCAS partners with Allscripts to make software available to EHR users

Pain and opioid risk assessment featuring SOAPP® & COMM® to be available through Allscripts Developer Program WALTHAM, Mass., July 2, 2018  — Inflexxion, Inc. announced today that its pain and opioid risk assessment software, PainCAS, is being featured as the Allscripts Developer Program (ADP) July app of the month.  PainCAS enables Allscripts ambulatory EHR users to… Read more »

Inflexxion, Inc. appoints Dr. Jody Green to Chief Scientific Officer

FOR IMMEDIATE RELEASE Inflexxion, Inc. appoints Dr. Jody Green to Chief Scientific Officer WALTHAM, MA (November 30, 2017) – Inflexxion, Inc. announced the appointment of Jody Green, PhD as Chief Scientific Officer, effective November 27. Green brings to Inflexxion a strong background and experience in the drug safety and opioid abuse space.  She will lead… Read more »

Commission on Combating Drug Addiction and the Opioid Crisis Recommendations Announced

Last week the President’s Commission on Combatting Drug Addiction and the Opioid Crisis released its final report, which included a list of 56 recommendations for addressing the many challenges this epidemic imposes on America.  The goal of these recommendations, as stated by the Commission, is “to combat the opioid crisis and drug addiction in our… Read more »

Inflexxion, Inc. appoints Bruno Lempernesse as New Chief Executive Officer

WALTHAM, MA (January 31, 2017) – Inflexxion, Inc. announced the appointment of Bruno Lempernesse to Chief Executive Officer, effective January 1. Lempernesse brings to Inflexxion over 20 years of experience in the life science and pharma industries.  Prior to joining Inflexxion in September as a Senior Advisor, Lempernesse served as Chief Operating Officer and General… Read more »

Inflexxion, Inc. announces death of founder, Chief Strategy Officer, Simon H. Budman, PhD

Inflexxion, Inc. sadly announces the untimely death of its founder, Simon H. Budman on Friday, January 13.  Dr. Budman was an internationally known behavioral psychologist, researcher, and author who was considered a thought leader in data driven health quality improvement. In 1989 he founded Inflexxion with a vision to develop interactive technologies that help people… Read more »

Inflexxion to provide data to FDA to evaluate opioid-related drug risks

Inflexxion, Inc. Awarded FDA Contract to Assist in Evaluation of Opioid-Related Drug Risks Inflexxion to provide analysis to the FDA from its surveillance data system on prescription drug abuse NEWTON, MA (October 17, 2016) – The US Food and Drug Administration (FDA) has awarded Inflexxion, Inc. a five-year, $10 million IDIQ contract.  The contract addresses,… Read more »

Scientific Presentation Demonstrates the Benefits of an Electronic Pain and Opioid Risk Assessment

Scientific Presentation Demonstrates the Benefits of an Electronic Pain and Opioid Risk Assessment in Documentation of Opioid Risk Stratification and Treatment Planning The scientific poster was presented by the Pain Management Center at Brigham and Women’s Hospital and Inflexxion, Inc. at the American Pain Society’s 34th Annual Scientific Meeting May 15, 2015 – Palm Springs, CA… Read more »

Inflexxion Study Finds the Association between Abuse of Prescription Opioids and Prescribed Availability is not Proportional

Inflexxion Study Finds the Association between Abuse of Prescription Opioids and Prescribed Availability is not Proportional Inflexxion’s NAVIPPRO data indicate a curvilinear, rather than linear, relationship between abuse and product availability April 16, 2015 – Newton, MA – Inflexxion, a company that develops behavioral change programs that reduce health-related risks, improve clinical outcomes, positively influence quality… Read more »